355 related articles for article (PubMed ID: 15964849)
1. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.
Bi Y; Stuelten CH; Kilts T; Wadhwa S; Iozzo RV; Robey PG; Chen XD; Young MF
J Biol Chem; 2005 Aug; 280(34):30481-9. PubMed ID: 15964849
[TBL] [Abstract][Full Text] [Related]
2. The effect of glucocorticoid on the synthesis of biglycan and decorin in human osteoblasts and bone marrow stromal cells.
Kimoto S; Cheng SL; Zhang SF; Avioli LV
Endocrinology; 1994 Dec; 135(6):2423-31. PubMed ID: 7988427
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture.
Kähäri VM; Larjava H; Uitto J
J Biol Chem; 1991 Jun; 266(16):10608-15. PubMed ID: 2037600
[TBL] [Abstract][Full Text] [Related]
4. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
Droguett R; Cabello-Verrugio C; Riquelme C; Brandan E
Matrix Biol; 2006 Aug; 25(6):332-41. PubMed ID: 16766169
[TBL] [Abstract][Full Text] [Related]
5. A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells.
Miura M; Chen XD; Allen MR; Bi Y; Gronthos S; Seo BM; Lakhani S; Flavell RA; Feng XH; Robey PG; Young M; Shi S
J Clin Invest; 2004 Dec; 114(12):1704-13. PubMed ID: 15599395
[TBL] [Abstract][Full Text] [Related]
6. Effects of transforming growth factor-beta1 on the gene expression of decorin, biglycan, and alkaline phosphatase in osteoblast precursor cells and more differentiated osteoblast cells.
Yamada T; Kamiya N; Harada D; Takagi M
Histochem J; 1999 Oct; 31(10):687-94. PubMed ID: 10576418
[TBL] [Abstract][Full Text] [Related]
7. Temporal regulation of hyaluronan and proteoglycan metabolism by human bone cells in vitro.
Fedarko NS; Termine JD; Young MF; Robey PG
J Biol Chem; 1990 Jul; 265(21):12200-9. PubMed ID: 2373688
[TBL] [Abstract][Full Text] [Related]
8. Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells.
Chen XD; Shi S; Xu T; Robey PG; Young MF
J Bone Miner Res; 2002 Feb; 17(2):331-40. PubMed ID: 11811564
[TBL] [Abstract][Full Text] [Related]
9. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy.
Yamachika S; Brayer J; Oxford GE; Peck AB; Humphreys-Beher MG
Clin Exp Rheumatol; 2000; 18(2):233-40. PubMed ID: 10812497
[TBL] [Abstract][Full Text] [Related]
10. The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells.
Inkson CA; Ono M; Bi Y; Kuznetsov SA; Fisher LW; Young MF
Cells Tissues Organs; 2009; 189(1-4):153-7. PubMed ID: 18701807
[TBL] [Abstract][Full Text] [Related]
11. Effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of decorin and biglycan by cultured osteoblastic cells.
Takagi M; Yamada T; Kamiya N; Kumagai T; Yamaguchi A
Histochem J; 1999 Jun; 31(6):403-9. PubMed ID: 10462226
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.
Hildebrand A; Romarís M; Rasmussen LM; Heinegård D; Twardzik DR; Border WA; Ruoslahti E
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):527-34. PubMed ID: 8093006
[TBL] [Abstract][Full Text] [Related]
13. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype.
Kinsella MG; Bressler SL; Wight TN
Crit Rev Eukaryot Gene Expr; 2004; 14(3):203-34. PubMed ID: 15248816
[TBL] [Abstract][Full Text] [Related]
14. Differential roles for small leucine-rich proteoglycans in bone formation.
Waddington RJ; Roberts HC; Sugars RV; Schönherr E
Eur Cell Mater; 2003 Oct; 6():12-21; discussion 21. PubMed ID: 14562268
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung.
Kolb M; Margetts PJ; Sime PJ; Gauldie J
Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1327-34. PubMed ID: 11350814
[TBL] [Abstract][Full Text] [Related]
16. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components.
Barry F; Boynton RE; Liu B; Murphy JM
Exp Cell Res; 2001 Aug; 268(2):189-200. PubMed ID: 11478845
[TBL] [Abstract][Full Text] [Related]
17. Biglycan-deficient mice have delayed osteogenesis after marrow ablation.
Chen XD; Allen MR; Bloomfield S; Xu T; Young M
Calcif Tissue Int; 2003 May; 72(5):577-82. PubMed ID: 12724831
[TBL] [Abstract][Full Text] [Related]
18. Biglycan knockout mice: new models for musculoskeletal diseases.
Young MF; Bi Y; Ameye L; Chen XD
Glycoconj J; 2002; 19(4-5):257-62. PubMed ID: 12975603
[TBL] [Abstract][Full Text] [Related]
19. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.
Chen XD; Fisher LW; Robey PG; Young MF
FASEB J; 2004 Jun; 18(9):948-58. PubMed ID: 15173106
[TBL] [Abstract][Full Text] [Related]
20. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin.
Schaefer L; Raslik I; Grone HJ; Schonherr E; Macakova K; Ugorcakova J; Budny S; Schaefer RM; Kresse H
FASEB J; 2001 Mar; 15(3):559-61. PubMed ID: 11259366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
